Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]HX4 PET Imaging of Tumor Hypoxia
NCT02584400Phase 2Terminated
- Sponsor
- Maastro Clinic
- Start
- May 2016
- Primary completion
- May 2017
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
A Phase 2 trial of Flortanidazole F-18 in esophageal cancer, rectal cancer, prostate cancer (PCa), glioma, brain metastasis (BM), sponsored by Maastro Clinic. Started May 2016; status: terminated.
02
Drugs
Flortanidazole F-18
03
Conditions
esophageal cancerrectal cancerprostate cancer (PCa)gliomabrain metastasis (BM)
Beyond the preview
Go deeper on NCT02584400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02584400.